Stockreport

Biogen Conference: Tau ASO CELIA Updates, Pre-Symptomatic Leqembi, SMA Phase 3 Plans [Yahoo! Finance]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF lowering — phase 1b showed ~60% CSF tau knockdown and reductions on tau PET, with the trial focused on dose/safety rather than a single registrational p-value. AHEAD 3 [Read more]